Teva Pharmaceutical Industries Limited (TEV) - Total Liabilities

Latest as of March 2026: €31.81 Billion EUR ≈ $37.19 Billion USD

Based on the latest financial reports, Teva Pharmaceutical Industries Limited (TEV) has total liabilities worth €31.81 Billion EUR (≈ $37.19 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Teva Pharmaceutical Industries Limited - Total Liabilities Trend (2015–2025)

This chart illustrates how Teva Pharmaceutical Industries Limited's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Teva Pharmaceutical Industries Limited to evaluate short-term liquidity relative to the company's equity base.

Teva Pharmaceutical Industries Limited Competitors by Total Liabilities

The table below lists competitors of Teva Pharmaceutical Industries Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Telefonaktiebolaget LM Ericsson B ADR NASDAQ:ERIC	USA	$186.22 Billion
JSW Steel Limited NSE:JSWSTEEL	India	Rs1.65 Trillion
Trip.com Group Ltd ADR NASDAQ:TCOM	USA	$100.60 Billion
People's Insurance of China Ltd SHG:601319	China	CN¥1.61 Trillion
Intact Financial Corporation TO:IFC	Canada	CA$41.59 Billion
SSE PLC ADR LS-50 1 F:SCTA	Germany	€17.23 Billion
Powszechna Kasa Oszczednosci Bank Polski SA WAR:PKO	Poland	zł524.58 Billion
HCL Technologies Limited NSE:HCLTECH	India	Rs411.17 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Teva Pharmaceutical Industries Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Teva Pharmaceutical Industries Limited (TEV) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.01	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.87	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.79	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Teva Pharmaceutical Industries Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Teva Pharmaceutical Industries Limited (2015–2025)

The table below shows the annual total liabilities of Teva Pharmaceutical Industries Limited from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	€32.83 Billion ≈ $38.39 Billion	-2.30%
2024-12-31	€33.61 Billion ≈ $39.29 Billion	-4.94%
2023-12-31	€35.35 Billion ≈ $41.33 Billion	+0.11%
2022-12-31	€35.31 Billion ≈ $41.29 Billion	-3.04%
2021-12-31	€36.42 Billion ≈ $42.58 Billion	-7.98%
2020-12-31	€39.58 Billion ≈ $46.27 Billion	-6.67%
2019-12-31	€42.41 Billion ≈ $49.58 Billion	-5.53%
2018-12-31	€44.89 Billion ≈ $52.48 Billion	-13.46%
2017-12-31	€51.87 Billion ≈ $60.64 Billion	-10.41%
2016-12-31	€57.90 Billion ≈ $67.69 Billion	+138.20%
2015-12-31	€24.31 Billion ≈ $28.42 Billion	--

About Teva Pharmaceutical Industries Limited

F:TEV Germany Drug Manufacturers - Specialty & Generic

Market Cap

$41.38 Billion

€35.40 Billion EUR

Market Cap Rank

#782 Global

#169 in Germany

Share Price

€30.40

Change (1 day)

+16.03%

52-Week Range

€13.15 - €30.50

All Time High

€57.25